Does BCR-ABL transcript type influence the prognosis of patients in chronic myelogenous leukemia chronic phase?

Does BCR-ABL transcript type influence the prognosis of patients in chronic myelogenous leukemia chronic phase?

Introduction and objective: In this study, we evaluated the influence of the transcript type on hematological and clinical parameters, as well as the event-free survival of 50 patients in the Chronic myeloid leukemia chronic phase. Methods: We reviewed the medical records of 55 patients with Chronic...

Full description

Bibliographic Details
Main Authors:	T.P. de Almeida Filho, P.A. Maia Filho, Maritza Cavalcante Barbosa, Luana Letícia Alves Dutra, Marilena Facundo de Castro, Fernando Barroso Duarte, Acy Telles de Souza Quixadá, Romélia Pinheiro Gonçalves Lemes
Format:	Article
Language:	English
Published:	Elsevier 2019-04-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S253113791930015X

Similar Items

Detection of bcr-abl Fusion Gene Expression in Chronic Myelogenous
by: Perpustakaan UGM, i-lib
Published: (2004)

Fluorescence in situ hybridization patterns of BCR/ABL1 fusion in chronic myelogenous leukemia at diagnosis
by: Poonam P Jain, et al.
Published: (2012-01-01)

Atypical Chronic Myelogenous Leukemia, BCR-ABL1 Negative: Diagnostic Criteria and Treatment Approaches
by: Panagiotis T. Diamantopoulos, et al.
Published: (2021-11-01)

Suppression of USP7 induces BCR-ABL degradation and chronic myelogenous leukemia cell apoptosis
by: Shuoyi Jiang, et al.
Published: (2021-05-01)

Protocol for isolation and analysis of the leukemia stem cells in BCR-ABL-driven chronic myelogenous leukemia mice
by: Chang Liu, et al.
Published: (2023-03-01)

“Preleukemic or smoldering” chronic myelogenous leukemia (CML):BCR-ABL1 positive: A brief case report
by: John M. Bennett, et al.
Published: (2015-01-01)

ROLE OF BREAK CLUSTER REGION (BCR) - ABELSON MURINE LEUKIMIA (ABL) EXAMINATION IN CHRONIC MYELOGENOUS LEUKEMIA (CML)
by: Agung Sosiawan
Published: (2015-07-01)

Association of Chronic Myelogenous (Basophilic) Leukemia and the BCR/ABL Mutation in a Yucatan Barrow (Sus scrofa domestica)
by: Catherine Takawira, et al.
Published: (2020-11-01)

<i>Trifolium Repens</i> Blocks Proliferation in Chronic Myelogenous Leukemia via the BCR-ABL/STAT5 Pathway
by: Federica Sarno, et al.
Published: (2020-02-01)

Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia.
by: Shovik Bandyopadhyay, et al.
Published: (2017-01-01)

Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a T315I BCR-ABL mutation
by: Franck E. Nicolini, et al.
Published: (2007-09-01)

CDK8/19 inhibition attenuates G1 arrest induced by BCR-ABL antagonists and accelerates death of chronic myelogenous leukemia cells
by: Alvina I. Khamidullina, et al.
Published: (2025-02-01)

Concomitant BCR-ABL1 positive chronic myelogenous leukemia emerging in a patient with MPL W515L associated primary myelofibrosis
by: Juan C. Gomez-Gelvez, MD, et al.
Published: (2016-03-01)

Mutant BCR-ABL clones in chronic myeloid leukemia
by: Michael S. Mathisen, et al.
Published: (2011-03-01)

Functionally deregulated AML1/RUNX1 cooperates with BCR-ABL to induce a blastic phase-like phenotype of chronic myelogenous leukemia in mice.
by: Kiyoko Yamamoto, et al.
Published: (2013-01-01)

BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia
by: Federica Loscocco, et al.
Published: (2019-09-01)

BCR-ABL promotes PTEN downregulation in chronic myeloid leukemia.
by: Cristina Panuzzo, et al.
Published: (2014-01-01)

Association of Clinical Features and Hematological Laboratories between Ph (+)/BCR-ABL (+) Chronic Myeloid Leukemia and Other Type of Ph/BCR-ABL Chronic Myeloid Leukemia
by: Wulyo Rajabto, et al.
Published: (2018-03-01)

Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK
by: Cross, N, et al.
Published: (2018)

Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia.
by: Foroni, L, et al.
Published: (2011)

Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia.
by: Dawne N Shelton, et al.
Published: (2022-01-01)

Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-κB signaling and depleting Bcr-Abl
by: Cao Qi, et al.
Published: (2010-05-01)

Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia
by: Dawne N. Shelton, et al.
Published: (2022-01-01)

The FABD domain is critical for the oncogenicity of BCR/ABL in chronic myeloid leukaemia
by: Renren Zheng, et al.
Published: (2024-06-01)

Characteristics of BCR–ABL gene variants in patients of chronic myeloid leukemia
by: Amin Huma, et al.
Published: (2021-06-01)

Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia
by: Diletta Fontana, et al.
Published: (2021-11-01)

Phosphorylation of BECLIN-1 by BCR-ABL suppresses autophagy in chronic myeloid leukemia
by: Chuanjiang Yu, et al.
Published: (2020-05-01)

Correction to: Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-κB signaling and depleting Bcr-Abl
by: Zhongzheng Lu, et al.
Published: (2021-12-01)

Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms
by: Xiaoying Lan, et al.
Published: (2016-11-01)

Navigating Challenges in Monitoring Chronic Myeloid Leukemia with Multiple BCR-ABL1 Transcripts
by: Brittany M. Smith, et al.
Published: (2021-11-01)

Imatinib-resistance without BCR/ABL Point Mutation in Chronic Myeloid Leukemia
by: Aytan Shirinova
Published: (2024-03-01)

Prognostic Significance of Transcript-Type BCR‐ABL1 in Chronic Myeloid Leukemia
by: matteo molica, et al.
Published: (2020-08-01)

BCR-ABL gene amplification in patients with chronic myeloid leukemia and imatinib resistance
by: S. I. Kutzev, et al.
Published: (2022-11-01)

PHILADELPHIA CHROMOSOME-NEGATIVE CHRONIC MYELOID LEUKEMIA WITH BCR::ABL1 FUSION
by: MCS Sousa, et al.
Published: (2024-10-01)

Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid Leukemia
by: M Yaghmaie, et al.
Published: (2005-09-01)

Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid Leukemia
by: Yaghmaie M., et al.
Published: (2005-09-01)

Fusion gene bcr-abl: From etiopathogenesis to the management of chronic myeloid leukemia
by: Tri Agusti Sholikah
Published: (2017-04-01)

p210BCR‐ABL1‐ Chronic myeloid leukemia presents with monocytosis
by: Xiaofei Wang, et al.
Published: (2020-05-01)

A double Philadelphia chromosome-positive chronic myeloid leukemia patient, co-expressing P210BCR-ABL1 and P195BCR-ABL1 isoforms
by: Raquel Vinhas, et al.
Published: (2018-11-01)

Transcripto BCR-ABL atípico en un paciente con leucemia mieloide crónica Atypical BCR-ABL transcript in a patient with chronic myeloid leukemia
by: Ana María Amor Vigil, et al.
Published: (2011-09-01)